• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立一种 HPLC-MS/MS 方法,用于手性拆分和定量检测尿液中的()-和()-沙丁胺醇及其硫酸结合代谢物,以研究立体选择性硫酸化。

Development of an HPLC-MS/MS Method for Chiral Separation and Quantitation of ()- and ()-Salbutamol and Their Sulfoconjugated Metabolites in Urine to Investigate Stereoselective Sulfonation.

机构信息

Pharmaceutical Analysis, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195 Berlin, Germany.

Pharmaceutical and Medicinal Chemistry (Computer-Aided Drug Design), Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195 Berlin, Germany.

出版信息

Molecules. 2023 Oct 21;28(20):7206. doi: 10.3390/molecules28207206.

DOI:10.3390/molecules28207206
PMID:37894685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10609612/
Abstract

The aim of this study was to develop and optimize a chiral HPLC-MS/MS method for quantitative analysis of ()-/()-salbutamol and ()-/()-salbutamol-4'--sulfate in human urine to allow for bioanalytical quantitation of the targeted analytes and investigations of stereoselectivity in the sulfonation pathway of human phase Ⅱ metabolism. For analytical method development, a systematic screening of columns and mobile phases to develop a separation via enantiomerically selective high performance liquid chromatography was performed. Electrospray ionization settings were optimized via multiple-step screening and a full factorial design-of-experiment. Both approaches were performed matrix-assisted and the predicted values were compared. The full factorial design was superior in terms of prediction power and knowledge generation. Performing a longitudinal excretion study in one healthy volunteer allowed for the calculation of excretion rates for all four targeted analytes. For this proof-of-concept, either racemic salbutamol or enantiopure levosalbutamol was administered perorally or via inhalation, respectively. A strong preference for sulfonation of ()-salbutamol for inhalation and peroral application was found in experiments. In previous studies phenol sulfotransferase 1A3 was described to be mainly responsible for salbutamol sulfonation in humans. Thus, in vitro and in silico investigations of the stereoselectivity of sulfotransferase 1A3 complemented the study and confirmed these findings.

摘要

本研究旨在开发和优化一种手性 HPLC-MS/MS 方法,用于定量分析人尿中的 ()-/()-沙丁胺醇和 ()-/()-沙丁胺醇-4'--硫酸盐,以实现对目标分析物的生物分析定量,并研究人Ⅱ相代谢中磺化途径的立体选择性。为了进行分析方法开发,系统地筛选了柱和流动相,以通过对映体选择性高效液相色谱法进行分离。通过多步筛选和完全析因实验设计优化了电喷雾电离条件。这两种方法都进行了基质辅助,并且比较了预测值。全因子设计在预测能力和知识生成方面具有优势。在一名健康志愿者中进行纵向排泄研究,允许计算所有四个目标分析物的排泄率。为此概念验证,分别通过口服或吸入给予外消旋沙丁胺醇或对映纯左沙丁胺醇。在实验中发现,吸入和口服应用时,()-沙丁胺醇的磺化强烈偏向于磺化。在先前的研究中,酚磺基转移酶 1A3 被描述为人类沙丁胺醇磺化的主要负责酶。因此,磺基转移酶 1A3 的体外和计算立体选择性研究补充了这项研究,并证实了这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/395a30ed1fbf/molecules-28-07206-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/45cb7a67a4eb/molecules-28-07206-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/d263e18d35f8/molecules-28-07206-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/e18761ca484b/molecules-28-07206-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/6c72283a9fc4/molecules-28-07206-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/9d1827238bc7/molecules-28-07206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/4c476838bef2/molecules-28-07206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/dedbd51cc116/molecules-28-07206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/56ee858798cd/molecules-28-07206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/47bffb52d1f3/molecules-28-07206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/3fec086c7855/molecules-28-07206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/856fad700094/molecules-28-07206-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/90bf4dae2c54/molecules-28-07206-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/b4701e67f401/molecules-28-07206-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/a768e8cb42fd/molecules-28-07206-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/8b6207fd1fc9/molecules-28-07206-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/395a30ed1fbf/molecules-28-07206-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/45cb7a67a4eb/molecules-28-07206-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/d263e18d35f8/molecules-28-07206-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/e18761ca484b/molecules-28-07206-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/6c72283a9fc4/molecules-28-07206-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/9d1827238bc7/molecules-28-07206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/4c476838bef2/molecules-28-07206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/dedbd51cc116/molecules-28-07206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/56ee858798cd/molecules-28-07206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/47bffb52d1f3/molecules-28-07206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/3fec086c7855/molecules-28-07206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/856fad700094/molecules-28-07206-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/90bf4dae2c54/molecules-28-07206-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/b4701e67f401/molecules-28-07206-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/a768e8cb42fd/molecules-28-07206-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/8b6207fd1fc9/molecules-28-07206-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d6/10609612/395a30ed1fbf/molecules-28-07206-g012.jpg

相似文献

1
Development of an HPLC-MS/MS Method for Chiral Separation and Quantitation of ()- and ()-Salbutamol and Their Sulfoconjugated Metabolites in Urine to Investigate Stereoselective Sulfonation.建立一种 HPLC-MS/MS 方法,用于手性拆分和定量检测尿液中的()-和()-沙丁胺醇及其硫酸结合代谢物,以研究立体选择性硫酸化。
Molecules. 2023 Oct 21;28(20):7206. doi: 10.3390/molecules28207206.
2
The pharmacokinetics of levosalbutamol: what are the clinical implications?左沙丁胺醇的药代动力学:临床意义是什么?
Clin Pharmacokinet. 2001 Jan;40(1):23-40. doi: 10.2165/00003088-200140010-00003.
3
Study on the determination and chiral inversion of R-salbutamol in human plasma and urine by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法测定人血浆和尿液中R-沙丁胺醇及其手性转化的研究
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:218-27. doi: 10.1016/j.jchromb.2015.08.020. Epub 2015 Aug 28.
4
Source discrimination of drug residues in wastewater: The case of salbutamol.废水中药物残留的来源鉴别:以沙丁胺醇为例。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 15;1023-1024:62-7. doi: 10.1016/j.jchromb.2016.04.033. Epub 2016 Apr 20.
5
Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometry.采用手性液相色谱串联质谱法测定生物基质中沙丁胺醇及其4-O-硫酸盐代谢物的对映体。
Rapid Commun Mass Spectrom. 1998;12(23):1899-910. doi: 10.1002/(SICI)1097-0231(19981215)12:23<1899::AID-RCM417>3.0.CO;2-I.
6
SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?SULT 1A3单核苷酸多态性与吸入沙丁胺醇对映体的单剂量药代动力学:部分运动员尿中水平升高的风险是否存在?
Drug Test Anal. 2015 Feb;7(2):109-13. doi: 10.1002/dta.1645. Epub 2014 Apr 1.
7
Chiral liquid chromatography-mass spectrometry (LC-MS/MS) method development for the detection of salbutamol in urine samples.用于检测尿液样本中沙丁胺醇的手性液相色谱-质谱联用(LC-MS/MS)方法开发。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jul 1;1025:83-91. doi: 10.1016/j.jchromb.2016.05.015. Epub 2016 May 13.
8
Validation of a chiral HPLC assay for (R)-salbutamol sulfate.硫酸(R)-沙丁胺醇手性高效液相色谱法的验证
J Pharm Biomed Anal. 2004 Jan 27;34(1):45-51. doi: 10.1016/j.japna.2003.08.020.
9
[Determination of sixteen antibiotics and four -agonists in human urine samples using ultra-performance liquid chromatography-tandem mass spectrometry based on high-throughput automatic solid-phase extraction].基于高通量自动固相萃取的超高效液相色谱-串联质谱法测定人尿液样本中的16种抗生素和4种β-激动剂
Se Pu. 2023 May 8;41(5):397-408. doi: 10.3724/SP.J.1123.2022.08025.
10
Quantitation of salbutamol in human urine by liquid chromatography-electrospray ionization mass spectrometry.采用液相色谱-电喷雾电离质谱法对人尿液中的沙丁胺醇进行定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):328-32. doi: 10.1016/j.jchromb.2005.11.041. Epub 2005 Dec 15.

引用本文的文献

1
Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.《年度禁用物质审查第17版——2023/2024年人类运动药物检测中的分析方法》
Drug Test Anal. 2025 Aug;17(8):1417-1442. doi: 10.1002/dta.3835. Epub 2024 Dec 28.

本文引用的文献

1
Human Sulfotransferase Assays With PAPS Production .利用3'-磷酸腺苷-5'-磷酰硫酸(PAPS)生成进行的人磺基转移酶检测
Front Mol Biosci. 2022 Feb 28;9:827638. doi: 10.3389/fmolb.2022.827638. eCollection 2022.
2
Functional Expression of All Human Sulfotransferases in Fission Yeast, Assay Development, and Structural Models for Isoforms SULT4A1 and SULT6B1.在裂殖酵母中功能性表达所有人类磺基转移酶,建立方法学并构建同工酶 SULT4A1 和 SULT6B1 的结构模型。
Biomolecules. 2020 Nov 6;10(11):1517. doi: 10.3390/biom10111517.
3
Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.
(R)-沙丁胺醇和(S)-沙丁胺醇对映体在马的肺上皮衬液和肺组织中的支气管肺药代动力学
Br J Clin Pharmacol. 2017 Jul;83(7):1436-1445. doi: 10.1111/bcp.13228. Epub 2017 Feb 8.
4
Chiral liquid chromatography-mass spectrometry (LC-MS/MS) method development for the detection of salbutamol in urine samples.用于检测尿液样本中沙丁胺醇的手性液相色谱-质谱联用(LC-MS/MS)方法开发。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jul 1;1025:83-91. doi: 10.1016/j.jchromb.2016.05.015. Epub 2016 May 13.
5
Study on the determination and chiral inversion of R-salbutamol in human plasma and urine by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法测定人血浆和尿液中R-沙丁胺醇及其手性转化的研究
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:218-27. doi: 10.1016/j.jchromb.2015.08.020. Epub 2015 Aug 28.
6
SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?SULT 1A3单核苷酸多态性与吸入沙丁胺醇对映体的单剂量药代动力学:部分运动员尿中水平升高的风险是否存在?
Drug Test Anal. 2015 Feb;7(2):109-13. doi: 10.1002/dta.1645. Epub 2014 Apr 1.
7
Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases.人细胞质硫转移酶对莱克多巴胺和沙丁胺醇的硫酸化作用。
J Biochem. 2012 Sep;152(3):275-83. doi: 10.1093/jb/mvs073. Epub 2012 Jul 4.
8
Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定人尿液中的沙丁胺醇和沙丁胺醇葡萄糖醛酸苷。
Drug Test Anal. 2011 Nov-Dec;3(11-12):820-7. doi: 10.1002/dta.367. Epub 2011 Nov 14.
9
Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD.福莫特罗治疗 COPD 患者急性和慢性时沙丁胺醇的剂量-反应曲线。
Int J Chron Obstruct Pulmon Dis. 2011;6:399-405. doi: 10.2147/COPD.S22179. Epub 2011 Jul 12.
10
(R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.(R)-沙丁胺醇治疗哮喘和慢性阻塞性气道疾病。
Expert Opin Pharmacother. 2011 May;12(7):1133-41. doi: 10.1517/14656566.2011.571210. Epub 2011 Apr 1.